Pay in 4 interest-free payments of $6.98 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
The GLP-1 RAs were originally developed for the treatment of type 2 diabetes mellitus (T2DM), but they soon showed promising effects in weight reduction [1, 2]
Inflammatory markers are linked with many diseases and infections but are also elevated in those who are overweight or obese
Its estimated that 12% of the country has used Ozempic or a similar GLP-1 drug, even with the high demand and steep price tag
Our patients at Centra Internal Medicine noticed modest weight reduction within the first four weeks of treatment
This is a perception or severity issue, not a safety concern
Your provider should also monitor your blood pressure, pulse, symptoms, and side effects throughout treatment
